Sales Enablement Collateral

At-home fecal immunochemical test (FIT) kits are discrete, convenient and easy to use.

A HIPAA-compliant, web-based patient outreach platform helps manage and optimize the CRC screening outreach process.

Personalized notifications associated with the FIT kit educate and empower patients to take action.

Achieve new levels of patient engagement with preventative care at-home testingBridgecom provides a standardized colorectal cancer (CRC) screening outreach program that accelerates patient compliance, significantly improves outcomes, and dramatically reduces the total cost of care for patient populations aged 50-75.

Clients who implement this evidenced-based program achieve improved HEDIS® quality measures by closing the gap in screening rates. Payers, physicians and other healthcare professionals can flag at-risk and rising-risk patients who require additional testing follow up to diagnose early stage cancers that are treatable at much lower cost.

2nd leading

cause of cancer death

in the U.S.1

90% survival rate when found and treated

early2

1 in 3 people

are not up-to-date with CRC

screenings3

The Southern California Permanente Medical Group screens nearly 90 percent of its eligible population for colorectal cancer, up from 45 percent a decade ago

Kaiser chose Bridgecom’s preventative care at-home testing fecal immunochemical test (FIT) kit and HIPAA-compliant, web-based patient outreach platform to revolutionize colorectal cancer care

About Kaiser Southern California Permanente Medical Group (SCPMG)

• Facility type: Self-governed, physician-led, prepaid medical group

• Locations: 15 medical centers and 221 medical offices

• Providers: 7,650+ independent, employed and contracted physicians and specialties

• Care focus: Permanente Medicine together with the Kaiser Foundation Health Plans andKaiser Foundation Hospitals

• Patient population:4.5M+ members

BACKGROUNDColorectal cancer (CRC) is the fourth most diagnosed cancer and the second leading cause of cancer death in the United States.1 Kaiser Permanente strives to be the national leader in quality for cancer care and its Healthcare EffectivenessDataandInformationSet(HEDIS)scoresillustrate its leading performance in CRC screening.2

PROGRAM OVERVIEWTo meet the health needs of its members, Kaiser estab-lished Complete Care in 2005, a coordinated care model that includes a collaborative approach through the use of innovative technology, an integrated system and dedicated care teams ensuring that patients with complex chronic conditions receive the proactive support, coordinated care, and follow up needed to maintain optimal health.

90% screened

50-75%FIT kit response rate

$300,000 late stage

treatment savings

Empower patients to undergo colorectal cancer screenings using the at-home FIT kit

1 in 20

1 in 3

will be diagnosed with CRC 3

are not up-to-date with CRC screenings 3

90%survival rate when found and treated early 2

Colorectal cancer is the

2nd leading cause of cancer-related deaths 1

A standardized CRC screening outreach program is proven to accelerate compliance, improve outcomes

and dramatically reduce the total cost of care.

The non-invasive FIT kit is discrete, safe and

easy for patients.

Dashboard analytics from the HIPAA-compliant, web-based patient outreach platform provide actionable

insight into patient behavior.

Colorectal Cancer may be curable if caught early. Activate your patient population to get screened using the evidence-based at-home FIT kits and

HIPAA-compliant, web-based patient outreach platform.

The Southern California Permanente Medical Group screens approximately 90 percent of its eligible population, up from 45 percent one decade ago.

90%

Call 888-685-7100 or visit bridgecomsolutions.com for more information on this patient engagement program.

1. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html2. http://seer.cancer.gov/statfacts/html/colorect.html3. https://fightcolorectalcancer.org/prevent/about-colorectal-cancer/facts-stats/

Early detection saves an average of $300,000 in late stage treatment costs per patient

50-75% CRC screening kit response rates

“Closed loop” reporting

HEDIS® Star Rating increase

Since we launched our screening program we have seen a remarkable decline in the number of cases of colorectal cancer and related deaths across a large, diverse population. said gastroenterologist Theodore R. Levin, MD, clinical lead for Kaiser Permanente’s colorectal cancer screening in Northern California.

“ “

2 Infographic

3 Case Study

5 Flyer

Empower patients to undergo colorectal cancer screenings using the at-home FIT kit

1 in 20

1 in 3

will be diagnosed with CRC 3

are not up-to-date with CRC screenings 3

90%survival rate when found and treated early 2

Colorectal cancer is the

2nd leading cause of cancer-related deaths 1

A standardized CRC screening outreach program is proven to accelerate compliance, improve outcomes

and dramatically reduce the total cost of care.

The non-invasive FIT kit is discrete, safe and

easy for patients.

Dashboard analytics from the HIPAA-compliant, web-based patient outreach platform provide actionable

insight into patient behavior.

Colorectal Cancer may be curable if caught early. Activate your patient population to get screened using the evidence-based at-home FIT kits and

HIPAA-compliant, web-based patient outreach platform.

The Southern California Permanente Medical Group screens approximately 90 percent of its eligible population, up from 45 percent one decade ago.

90%

Call 888-685-7100 or visit bridgecomsolutions.com for more information on this patient engagement program.

1. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html2. http://seer.cancer.gov/statfacts/html/colorect.html3. https://fightcolorectalcancer.org/prevent/about-colorectal-cancer/facts-stats/

Early detection saves an average of $300,000 in late stage treatment costs per patient

50-75% CRC screening kit response rates

“Closed loop” reporting

HEDIS® Star Rating increase

Since we launched our screening program we have seen a remarkable decline in the number of cases of colorectal cancer and related deaths across a large, diverse population. said gastroenterologist Theodore R. Levin, MD, clinical lead for Kaiser Permanente’s colorectal cancer screening in Northern California.

“ “

The Southern California Permanente Medical Group screens nearly 90 percent of its eligible population for colorectal cancer, up from 45 percent a decade ago

Kaiser chose Bridgecom’s preventative care at-home testing fecal immunochemical test (FIT) kit and HIPAA-compliant, web-based patient outreach platform to revolutionize colorectal cancer care

About Kaiser Southern California Permanente Medical Group (SCPMG)

• Facility type: Self-governed, physician-led, prepaid medical group

• Locations: 15 medical centers and 221 medical offices

• Providers: 7,650+ independent, employed and contracted physicians and specialties

• Care focus: Permanente Medicine together with the Kaiser Foundation Health Plans and Kaiser Foundation Hospitals

• Patient population: 4.5M+ members

BACKGROUNDColorectal cancer (CRC) is the fourth most diagnosed cancer and the second leading cause of cancer death in the United States.1 Kaiser Permanente strives to be the national leader in quality for cancer care and its Healthcare EffectivenessDataandInformationSet(HEDIS)scoresillustrate its leading performance in CRC screening.2

PROGRAM OVERVIEWTo meet the health needs of its members, Kaiser estab-lished Complete Care in 2005, a coordinated care model that includes a collaborative approach through the use of innovative technology, an integrated system and dedicated care teams ensuring that patients with complex chronic conditions receive the proactive support, coordinated care, and follow up needed to maintain optimal health.

90% screened

50-75% FIT kit response rate

$300,000 late stage

treatment savings

Outreach began with patient letters mailed to encourage screenings.

The program has evolved over the past decade to include proactive outreach with a combination of touches (mail, phone, email, text), preventa-tive care at-home fecal immunochemical test

(FIT) kit distribution, patient surveillance, and EMR “closed loop” reporting.

In 2017, Kaiser screened 90 percent of its population in Southern California by performing 2,106,123CRCscreenings — upfrom45percenta decade ago.

SOLUTIONKaiser is focused on providing large-scale, con-tinuous patient outreach solutions. Recognizing the link between early detection, screening and improved outcomes for colorectal cancer, SCPMG engaged Bridgecom on an ongoing basis to mail FIT kits and instructions directly to patients’ homes to be screened based on age or family history.

Its innovative, patented packaging process for FIT kits meets USPS regulations for biohazards and costs the equivalent of mailing one letter.

Inadditiontoitspatentedfulfillmentsolutions,Bridgecomoffersstandardizedprocessmodelswith customization capabilities and multichan-nel communication options. A “wrap-around”

program of services covers the “last mile” of communication through an interactive HIPAA-compliant, web-based patient outreach platform that is rules-driven and provides an API for “closed loop” reporting.

The platform helps Kaiser manage and opti-mize its CRC screening outreach process, drive compliance, and improve education, awareness and participation. Each outreach campaign includes a combination of four reminder touch-points delivered at staggered intervals as many times as needed to empower each patient to takeaction.Dashboardreportingallowsstafftomonitor which patients have yet to return their tests in addition to those deemed at risk need-ing immediate attention.

1. https://jamanetwork.com/journals/jama/article-abstract/27322992. https://permanente.org/wp-content/uploads/2018/10/Fact-Sheet_Cancer-care_2018.pdf

RESULTSIn California, Kaiser Permanente members between the ages 50 and 75 are screened for CRC at 90 percent. SCPMG regularly sees a 50 to 75 percent CRC screening response rate (industry average is 17 to 20 percent) and saves an average of $300,000 per patient in late stage treatment avoidance costs.

As a direct result of this standardized CRC disease screening and detection outreach program, Kaiser Permanente Southern California’s Medicare Plan received a 5 out of 5 rating from the National Committee on Quality Assurance (NCQA) in its Medicare Health Insurance Plan Ratings for 2015-2016. CRCscreeningcontributedtoitsincreasedHEDISStarRating.

At-home fecal immunochemical test (FIT) kits are discrete, convenient and easy to use.

A HIPAA-compliant, web-based patient outreach platform helps manage and optimize the CRC screening outreach process.

Personalized notifications associated with the FIT kit educate and empower patients to take action.

Achieve new levels of patient engagement with preventative care at-home testingBridgecom provides a standardized colorectal cancer (CRC) screening outreach program that accelerates patient compliance, significantly improves outcomes, and dramatically reduces the total cost of care for patient populations aged 50-75.

Clients who implement this evidenced-based program achieve improved HEDIS® quality measures by closing the gap in screening rates. Payers, physicians and other healthcare professionals can flag at-risk and rising-risk patients who require additional testing follow up to diagnose early stage cancers that are treatable at much lower cost.

2nd leading

cause of cancer death

in the U.S.1

90% survival rate when found and treated

early2

1 in 3 people

are not up-to-date with CRC

screenings3

Contact us at 888.685.7100 or visit bridgecomsolutions.com for more information on this patient engagement program.

1. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html 2. http://seer.cancer.gov/statfacts/html/colorect.html3. https://fightcolorectalcancer.org/prevent/about-colorectal-cancer/facts-stats/

Our storySince day one, Bridgecom has focused on providing large-scale, continuous patient outreach solutions. Anchored by 30 years’ expertise in Medicare/Medicaid member communication fulfillment, Bridgecom’s HIPAA-compliant, web-based platform and workflow processes help health payers, providers, accountable care organizations (ACOs) and medical groups standardize and distribute preventative care at-home CRC disease screening FIT kits to target populations.

FIT kit distribution, patient outreach and engagement The Bridgecom CRC screening outreach program offers standardized process models with customization capabilities, patented fulfillment solutions, and multi-channel communication options.

In 2018, Bridgecom distributed 1,025,863 FIT kits

Collateral In-Use